Cover Image
市場調查報告書

歐洲的整形外科用生醫材料市場

Europe Markets for Orthopedic Biomaterials 2011-2021

出版商 iData Research Inc. 商品編碼 288794
出版日期 內容資訊 英文 350 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的整形外科用生醫材料市場 Europe Markets for Orthopedic Biomaterials 2011-2021
出版日期: 2015年06月01日 內容資訊: 英文 350 Pages
簡介

歐洲的整形外科用生醫材料市場預計至2019年成為3億7,670萬歐元。尤其玻尿酸關節內補充是最大的市場區隔。

本報告提供同市場概要各市場區隔、各國概要、預測、策略性市場機會等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 調查方法

第3章 歐洲的整形外科用生醫材料市場

  • 簡介
    • 產品
  • 目前匯率
  • 市場概要
  • 趨勢分析
  • 促進因素與阻礙因素
  • 競爭分析
  • 合併、收購

第4章 國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第5章 人工骨骼替代物市場

  • 簡介
  • 市場概要
    • 各適應症
    • 各市場區隔
  • 市場分析與預測
    • 市場整體
    • 異體移植片市場
    • 合成市場
    • 脫鈣骨基質市場
  • 促進因素與阻礙因素
  • 競爭分析

第6章 玻尿酸關節內補充市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 市場整體
    • 單次注射市場
    • 3次輸液市場
    • 5次輸液市場
  • 促進因素與阻礙因素
  • 競爭分析

第7章 骨骼成型蛋白生長因子治療市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭分析

第8章 自體軟骨細胞移植市場

  • 簡介
    • 自體軟骨細胞移植治療的未來性
  • 市場分析與預測
  • 促進因素與阻礙因素
  • 競爭分析

簡稱

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_EUOB15_RPT

The European market for orthopedic materials is segmented into bone graft substitutes (BGS), which includes allograft, synthetic and demineralized bone matrices (DBM); bone morphogenetic protein (BMP) growth factors; hyaluronic acid (HA) viscosupplementation; and autologous chondrocyte implantation (ACI).

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation injections, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantations (ACI). The HA market experienced significant contractions in 2012 and 2013 due to the extreme price competition resulting from an increase in competition, especially in Germany.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 EUROPEAN MARKETS FOR ORTHOPEDIC BIOMATERIALS
  • 1.2 BONE GRAFT SUBSTITUTE MARKET
  • 1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET
  • 1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
  • 1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET
  • 1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
  • 1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
  • 1.9 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1 INTRODUCTION
    • 3.1.1 Products
      • 3.1.1.1 Growth Factors
      • 3.1.1.2 Bone Graft Substitutes
      • 3.1.1.3 Hyaluronic Acid Viscosupplementation
      • 3.1.1.4 Autologous Chondrocyte Implantation
  • 3.2 CURRENCY EXCHANGE RATE
  • 3.3 MARKET OVERVIEW
  • 3.4 TREND ANALYSIS
  • 3.5 DRIVERS AND LIMITERS
    • 3.5.1 Market Drivers
    • 3.5.2 Market Limiters
  • 3.6 COMPETITIVE ANALYSIS
  • 3.7 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1 INTRODUCTION
    • 4.1.1 Population
    • 4.1.2 GDP per Capita
    • 4.1.3 Price Index
  • 4.2 GERMANY
  • 4.3 FRANCE
  • 4.4 UNITED KINGDOM
  • 4.5 ITALY
  • 4.6 SPAIN
  • 4.7 BENELUX
  • 4.8 SCANDINAVIA
  • 4.9 AUSTRIA
  • 4.10 SWITZERLAND
  • 4.11 PORTUGAL

BONE GRAFT SUBSTITUTE MARKET

  • 5.1 INTRODUCTION
    • 5.1.1 Volumes Represented per Procedure
  • 5.2 MARKET OVERVIEW
    • 5.2.1 Bone Graft Substitute Market by Indication
    • 5.2.2 Bone Graft Substitute Market by Segment
  • 5.3 MARKET ANALYSIS AND FORECAST
    • 5.3.1 Total Bone Graft Substitute Market
    • 5.3.2 Total Allograft Market
      • 5.3.2.1 Total Allograft Spine Market
        • 5.3.2.1.1 Allograft Cervical Spine Market
        • 5.3.2.1.2 Allograft Thoracolumbar Spine Market
      • 5.3.2.2 Allograft Trauma and Reconstruction Market
      • 5.3.2.3 Allograft Craniomaxillofacial Market
    • 5.3.3 Total Synthetic Market
      • 5.3.3.1 Total Synthetic Spine Market
        • 5.3.3.1.1 Synthetic Cervical Spine Market
        • 5.3.3.1.2 Synthetic Thoracolumbar Spine Market
      • 5.3.3.2 Synthetic Trauma and Reconstruction Market
      • 5.3.3.3 Synthetic Craniomaxillofacial Market
    • 5.3.4 Total Demineralized Bone Matrix Market
      • 5.3.4.1 Total Demineralized Bone Matrix Spine Market
        • 5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market
        • 5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market
      • 5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market
      • 5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market
  • 5.4 DRIVERS AND LIMITERS
    • 5.4.1 Market Drivers
    • 5.4.2 Market Limiters
  • 5.5 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 6.1 INTRODUCTION
  • 6.2 MARKET OVERVIEW
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Total Hyaluronic Acid Viscosupplementation Market
    • 6.3.2 Single-Injection Market
    • 6.3.3 Three-Injection Market
    • 6.3.4 Five-Injection Market
  • 6.4 DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • 7.1 INTRODUCTION
  • 7.2 MARKET ANALYSIS AND FORECAST
  • 7.3 MARKET DRIVERS AND LIMITERS
    • 7.3.1 Market Drivers
    • 7.3.2 Market Limiters
  • 7.4 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • 8.1 INTRODUCTION
    • 8.1.1 Future of ACI Treatments
  • 8.2 MARKET ANALYSIS AND FORECAST
  • 8.3 DRIVERS AND LIMITERS
    • 8.3.1 Market Drivers
    • 8.3.2 Market Limiters
  • 8.4 COMPETITIVE ANALYSIS

ABBREVIATIONS

Back to Top